Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease

The Lancet Infectious Diseases

Volumn 9, Issue 5, 2009, Pages 301-311

  Brouqui, Philippe ^a   Puro, Vincenzo ^b   Fusco, Francesco M ^b   Bannister, Barbara ^c   Schilling, Stephan ^d   Follin, Per ^e   Gottschalk, René ^f   Hemmer, Robert ^g   Maltezou, Helena C ^h   Ott, Kristi ⁱ   Peleman, Renaat ^j   Perronne, Christian ^k   Sheehan, Gerard ^l   Siikamäki, Heli ^m   Skinhoj, Peter ⁿ   Ippolito, Giuseppe ^b  

^a HÔPITAL NORD   (France)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d GOETHE UNIVERSITY   (Germany)

^e LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^f Public Health Office   (Germany)

^g Luxembourg Central Hospital   (Luxembourg)

^h Hellenic Centre for Disease Control and Prevention   (Greece)

ⁱ WEST TALLINN CENTRAL HOSPITAL   (Estonia)

^j GHENT UNIVERSITY HOSPITAL   (Belgium)

^k Raymond Poincaré University Hospital   (France)

^l MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^m HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁿ Rigshospitalet   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOSAFETY; CHILD CARE; EMERGENCY PHYSICIAN; EMERGENCY WARD; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HYGIENE; INFECTION; INFECTION CONTROL; INTENSIVE CARE; INTENSIVE CARE UNIT; INTERPERSONAL COMMUNICATION; LABORATORY; LABORATORY TEST; PATIENT CARE; PEDIATRICIAN; POINT OF CARE TESTING; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW;

ADULT; CHILD; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; EMERGENCY SERVICE, HOSPITAL; EUROPE; HUMANS; INFECTION CONTROL; PATIENT ISOLATION; PATIENT ISOLATORS;

EID: 64849114548     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(09)70070-2     Document Type: Review

References (110)

1. Anderson R.M., Fraser C., Ghani A.C., et al. Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci 359 (2004) 1091-1105
2. Haas W.H., Breuer T., Pfaff G., et al. Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis 36 (2003) 1254-1258
3. Johnson K.M., and Monath T.P. Imported Lassa fever-reexamining the algorithms. N Engl J Med 323 (1990) 1139-1141
4. US Department of Health and Human Services, Centers for Diseases Control and Prevention, and National Institutes of Health. Biosafety in microbiological and biomedical laboratories (BMBL), 5th edn (February, 2007). http://www.cdc.gov/od/ohs/biosfty/bmbl5/bmbl5toc.htm (accessed Feb 24, 2009).
5. Johnson J.E., and Kadull P.J. Laboratory-acquired Q fever: a report of fifty cases. Am J Med 41 (1966) 391-403
6. Oster C.N., Burke D.S., Kenyon R.H., Ascher M.S., Harber P., and Pedersen Jr. C.E. Laboratory-acquired Rocky Mountain spotted fever: the hazard of aerosol transmission. N Engl J Med 297 (1977) 859-863
7. Woo J.H., Cho J.Y., Kim Y.S., et al. A case of laboratory-acquired murine typhus. Korean J Intern Med 5 (1990) 118-122
8. Lake G.C., and Francis E. Six cases of tularemia occurring in laboratory workers. Public Health Rep 37 (1922) 392-413
9. Burmeister R.W., Tigertt W.D., and Overholt E.L. Laboratory-acquired pneumonic plague. Report of a case and review of previous cases. Ann Intern Med 56 (1962) 789-800
10. Schlech III W.F., Turchik J.B., Westlake Jr. R.E., Klein G.C., Band J.D., and Weaver R.E. Laboratory-acquired infection with Pseudomonas pseudomallei (melioidosis). N Engl J Med 305 (1981) 1133-1135
11. Hummeler K., Davidson W.L., Henle W., Laboccetta A.C., and Ruch H.G. Encephalomyelitis due to infection with Herpesvirus simiae (herpes B virus); a report of two fatal, laboratory-acquired cases. N Engl J Med 261 (1959) 64-68
12. Stille W., Bohle E., Helm E., van R.W., and Siede W. An infectious disease transmitted by Cercopithecus aethiops ("Green monkey disease"). Ger Med Mon 13 (1968) 470-478
13. Leifer E., Gocke D.J., and Bourne H. Lassa fever, a new virus disease of man from West Africa: II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease. Am J Trop Med Hyg 19 (1970) 677-679
14. Kawamata J., Yamanouchi T., Dohmae K., et al. Control of laboratory acquired hemorrhagic fever with renal syndrome (HFRS) in Japan. Lab Anim Sci 37 (1987) 431-436
15. Lee H.W., and Johnson K.M. Laboratory-acquired infections with Hantaan virus, the etiologic agent of Korean hemorrhagic fever. J Infect Dis 146 (1982) 645-651
16. Avsic-Zupanc T., Poljak M., Maticic M., et al. Laboratory acquired tick-borne meningoencephalitis: characterisation of virus strains. Clin Diagn Virol 4 (1995) 51-59
17. Barry M., Russi M., Armstrong L., et al. Brief report: treatment of a laboratory-acquired Sabia virus infection. N Engl J Med 333 (1995) 294-296
18. Ryder R.W., and Gandsman E.J. Laboratory-acquired Sabia virus infection. N Engl J Med 333 (1995) 1716
19. Centers for Disease Control and Prevention. Laboratory-acquired West Nile virus infections-United States, 2002. MMWR Morb Mortal Wkly Rep 51 (2002) 1133-1135
20. Loeb M., Zando I., Orvidas M.C., Bialachowski A., Groves D., and Mahoney J. Laboratory-acquired vaccinia infection. Can Commun Dis Rep 29 (2003) 134-136
21. Raoult D., Renesto P., and Brouqui P. Laboratory infection of a technician by mimivirus. Ann Intern Med 144 (2006) 702-703
22. Kruse R.H., Puckett W.H., and Richardson J.H. Biological safety cabinetry. Clin Microbiol Rev 4 (1991) 207-241
23. Lim P.L., Kurup A., Gopalakrishna G., et al. Laboratory-acquired severe acute respiratory syndrome. N Engl J Med 350 (2004) 1740-1745
24. European Network of Infectious Diseases. Description. http://www.eunid.eu/description.asp (accessed Mar 5, 2009).
25. Bannister B., Puro V., Fusco F.M., Heptonstall J., Ippolito G., and EUNID Working Group. Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases. Lancet Infect Dis 9 (2009) 45-56
26. Smith P.W., Anderson A.O., Christopher G.W., et al. Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement. Biosecur Bioterror 4 (2006) 351-365
27. Senior K. Recent Singapore SARS case a laboratory accident. Lancet Infect Dis 3 (2003) 679
28. Loeb M.B. Severe acute respiratory syndrome: preparedness, management, and impact. Infect Control Hosp Epidemiol 25 (2004) 1017-1019
29. Kwok K.O., Leung G.M., Lam W.Y., and Riley S. Using models to identify routes of nosocomial infection: a large hospital outbreak of SARS in Hong Kong. Proc Biol Sci 274 (2007) 611-617
30. American Biological Safety Association. Risk group classification for infectious agents (2006). http://www.absa.org/riskgroups/index.html (accessed Feb 24, 2009).
31. Osorio S., Sarria C., Gonzalez-Ruano P., Casal E.C., and Garcia A. Nosocomial transmission of Q fever. J Hosp Infect 54 (2003) 162-163
32. Ludlam H., Wreghitt T.G., Thornton S., et al. Q fever in pregnancy. J Infect 34 (1997) 75-78
33. Racult D., and Stein A. Q fever during pregnancy-a risk for women, fetuses, and obstetricians. N Engl J Med 330 (1994) 371
34. Weber D.J., and Rutala W.A. Risks and prevention of nosocomial transmission of rare zoonotic diseases. Clin Infect Dis 32 (2001) 446-456
35. Ashdown L.R. Nosocomial infection due to Pseudomonas pseudomallei: two cases and an epidemiologic study. Rev Infect Dis 1 (1979) 891-894
36. Jensen P.A., Lambert L.A., Iademarco M.F., and Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 54 RR-17 (2005) 1-141
37. Jain A., and Mondal R. Extensively drug-resistant tuberculosis: current challenges and threats. FEMS Immunol Med Microbiol 53 (2008) 145-150
38. European Commission. Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risk related to exposure to biological agents at work. Official Journal of the European Communities Oct 17, 2000. L262/21. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2000:262:0021:0045:EN:PDF (accessed Feb 24, 2009).
39. Henderson D.A., Inglesby T.V., Bartlett J.G., et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281 (1999) 2127-2137
40. Bossi P., Tegnell A., Baka A., et al. Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses. Euro Surveill 9 (2004) E11-E12
41. Parola P., de Lamballerie X., Jourdan J., et al. Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis 12 (2006) 1493-1499
42. Markotic A. Human-to-human transmission of hantaviruses. Lancet 350 (1997) 596
43. WHO. Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care: WHO interim guidelines. http://www.who.int/csr/resources/publications/WHO_CDS_EPR_2007_6c.pdf (accessed Feb 24, 2009).
44. Parry J. WHO issues guidelines to manage any future SARS outbreak. BMJ 327 (2003) 411
45. Holmes G.P., Hilliard J.K., Klontz K.C., et al. B virus (Herpesvirus simiae) infection in humans: epidemiologic investigation of a cluster. Ann Intern Med 112 (1990) 833-839
46. Chang W.T., Kao C.L., Chung M.Y., et al. SARS exposure and emergency department workers. Emerg Infect Dis 10 (2004) 1117-1119
47. Chen Y.C., Huang L.M., Chan C.C., et al. SARS in hospital emergency room. Emerg Infect Dis 10 (2004) 782-788
48. Borgundvaag B., Ovens H., Goldman B., et al. SARS outbreak in the Greater Toronto Area: the emergency department experience. CMAJ 171 (2004) 1342-1344
49. Farquharson C., and Baguley K. Responding to the severe acute respiratory syndrome (SARS) outbreak: lessons learned in a Toronto emergency department. J Emerg Nurs 29 (2003) 222-228
50. Anathallee M., Curphey A., Beeching N., Carley S., Crawford I., and Mackway-Jones K. Emergency departments (EDs) in the United Kingdom (UK) are not prepared for emerging biological threats and bioterrorism. J Infect 54 (2007) 12-17
51. WHO. WHO issues consensus document on the epidemiology of SARS. Wkly Epidemiol Rec 78 (2003) 373-375
52. Seto W.H., Tsang D., Yung R.W., et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 361 (2003) 1519-1520
53. Centers for Disease Control and Prevention. Guideline for isolation precaution: preventing transmission of infectious agents in healthcare settings 2007. http://www.cdc.gov/ncidod/dhqp/gl_isolation.html (accessed Feb 24, 2009).
54. Centers for Disease Control and Prevention. Respiratory hygiene/cough etiquette in healthcare settings. http://www.cdc.gov/flu/professionals/infectioncontrol/resphygiene.htm (accessed Feb 24, 2009).
55. Bridges C.B., Kuehnert M.J., and Hall C.B. Transmission of influenza: implications for control in health care settings. Clin Infect Dis 37 (2003) 1094-1101
56. Srinivasan A., McDonald L.C., Jernigan D., et al. Foundations of the severe acute respiratory syndrome preparedness and response plan for healthcare facilities. Infect Control Hosp Epidemiol 25 (2004) 1020-1025
57. Srinivasan A., Jernign D.B., Liedtke L., and Strausbaugh L. Hospital preparedness for severe acute respiratory syndrome in the United States: views from a national survey of infectious diseases consultants. Clin Infect Dis 39 (2004) 272-274
58. Ippolito G., Puro V., and Heptonstall J. Hospital preparedness to bioterrorism and other infectious disease emergencies. Cell Mol Life Sci 63 (2006) 2213-2222
59. WHO. Laboratory biosafety manual, 3rd edn. http://www.who.int/csr/resources/publications/biosafety/WHO_CDS_CSR_LYO_2004_11/en/ (accessed Feb 24, 2009).
60. Charles P.G. Early diagnosis of lower respiratory tract infections (point-of-care tests). Curr Opin Pulm Med 14 (2008) 176-182
61. Purssell E. Preventing nosocomial infection in paediatric wards. J Clin Nurs 5 (1996) 313-318
62. Harris J.A. Pediatric nosocomial infections: children are not little adults. Infect Control Hosp Epidemiol 18 (1997) 739-742
63. Chan S.S., Leung D.Y., Wong E.M., et al. Balancing infection control practices and family-centred care in a cohort of paediatric suspected severe acute respiratory syndrome patients in Hong Kong. J Paediatr Child Health 42 (2006) 20-27
64. Koller D.F., Nicholas D.B., Goldie R.S., Gearing R., and Selkirk E.K. Bowlby and Robertson revisited: the impact of isolation on hospitalized children during SARS. J Dev Behav Pediatr 27 (2006) 134-140
65. Hugonnet S., and Pittet D. Transmission of severe acute respiratory syndrome in critical care: do we need a change?. Am J Respir Crit Care Med 169 (2004) 1177-1178
66. Fowler R.A., Guest C.B., Lapinsky S.E., et al. Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Am J Respir Crit Care Med 169 (2004) 1198-1202
67. Scales D.C., Green K., Chan A.K., et al. Illness in intensive care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 9 (2003) 1205-1210
68. Peiris J.S., Chu C.M., Cheng V.C., et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361 (2003) 1767-1772
69. So L.K., Lau A.C., Yam L.Y., et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 361 (2003) 1615-1617
70. Xue X., Zhu J., Pei L., et al. Clinical analysis of 45 patients with severe acute respiratory syndrome [in Chinese]. Beijing Da Xue Xue Bao 35 suppl (2003) 44-46
71. Zhao Z., Zhang F., Xu M., et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 52 (2003) 715-720
72. Wu W., Wang J., Liu P., et al. A hospital outbreak of severe acute respiratory syndrome in Guangzhou, China. Chin Med J (Engl) 116 (2003) 811-818
73. Xiao Z., Li Y., Chen R., Li S., Zhong S., and Zhong N. A retrospective study of 78 patients with severe acute respiratory syndrome. Chin Med J (Engl) 116 (2003) 805-810
74. Yam L.Y., Chan A.Y., Cheung T.M., Tsui E.L., Chan J.C., and Wong V.C. Non-invasive versus invasive mechanical ventilation for respiratory failure in severe acute respiratory syndrome. Chin Med J (Engl) 118 (2005) 1413-1421
75. Hui D.S., Hall S.D., Chan M.T., et al. Noninvasive positive-pressure ventilation: an experimental model to assess air and particle dispersion. Chest 130 (2006) 730-740
76. Lapinsky S.E., and Hawryluck L. ICU management of severe acute respiratory syndrome. Intensive Care Med 29 (2003) 870-875
77. WHO. Practical guidelines for infection control in health care facilities. http://www.searo.who.int/LinkFiles/Publications_PracticalguidelinSEAROpub-41.pdf (accessed Feb 24, 2009).
78. Yam L.Y., Chen R.C., and Zhong N.S. SARS: ventilatory and intensive care. Respirology 8 suppl (2003) S31-S35
79. Centers for Disease Control and Prevention. Severe acute respiratory syndrome-Singapore, 2003. MMWR Morb Mortal Wkly Rep 52 (2003) 405-411
80. Christian M.D., Loutfy M., McDonald L.C., et al. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis 10 (2004) 287-293
81. McCormick J.B., and Hoch S.F. Filoviruses. In: Porterfield J.S. (Ed). Kass handbook of infectious diseases: exotic viral infections (1995), Chapman and Hall, London 319-328
82. Richards G.A., Murphy S., Jobson R., et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med 28 (2000) 240-244
83. Yu I.T., and Sung J.J. The epidemiology of the outbreak of severe acute respiratory syndrome (SARS) in Hong Kong-what we do know and what we don't. Epidemiol Infect 132 (2004) 781-786
84. Li F., Tian X.L., Hou J., Wu Q.H., and Zhang P.Y. Application of Ris/PACS in the prevention and treatment of SARS at the hospital radiology [in Chinese]. Zhongguo Yi Liao Qi Xie Za Zhi 29 (2005) 212-214
85. Tomlinson B., and Cockram C. SARS: experience at Prince of Wales Hospital, Hong Kong. Lancet 361 (2003) 1486-1487
86. Loeb M., McGeer A., Henry B., et al. SARS among critical care nurses, Toronto. Emerg Infect Dis 10 (2004) 251-255
87. Mehta A.C., Prakash U.B., Garland R., et al. American College of Chest Physicians and American Association for Bronchology [corrected] consensus statement: prevention of flexible bronchoscopy-associated infection. Chest 128 (2005) 1742-1755
88. The American Institute of Architects. Guidelines for design and construction of hospital and health care facilities, 2001 (2001), American Institute of Architects Press, Washington, DC
89. Lau J.T., Tsui H., Lau M., and Yang X. SARS transmission, risk factors, and prevention in Hong Kong. Emerg Infect Dis 10 (2004) 587-592
90. Sampathkumar P., Temesgen Z., Smith T.F., and Thompson R.L. SARS: epidemiology, clinical presentation, management, and infection control measures. Mayo Clin Proc 78 (2003) 882-890
91. Wenzel R.P., and Edmond M.B. Listening to SARS: lessons for infection control. Ann Intern Med 139 (2003) 592-593
92. Ho A.S., Sung J.J., and Chan-Yeung M. An outbreak of severe acute respiratory syndrome among hospital workers in a community hospital in Hong Kong. Ann Intern Med 139 (2003) 564-567
93. Wenzel R.P., and Edmond M.B. Managing SARS amidst uncertainty. N Engl J Med 348 (2003) 1947-1948
94. Chiang C.H., Chen H.M., Shih J.F., Su W.J., and Perng R.P. Management of hospital-acquired severe acute respiratory syndrome with different disease spectrum. J Chin Med Assoc 66 (2003) 328-338
95. Muscarella L.F. Recommendations for the prevention of transmission of SARS during GI endoscopy. Gastrointest Endosc 60 (2004) 792-795
96. Keskiner R., Ergonul O., Demiroglu Z., Eren S., Baykam N., and Dokuzoguz B. Risk of tuberculous infection among healthcare workers in a tertiary-care hospital in Ankara, Turkey. Infect Control Hosp Epidemiol 25 (2004) 1067-1071
97. Ho S.S., Chan P.L., Wong P.K., et al. Eye of the storm: the roles of a radiology department in the outbreak of severe acute respiratory syndrome. AJR Am J Roentgenol 181 (2003) 19-24
98. King A.D., Ching A.S., Chan P.L., et al. Severe acute respiratory syndrome: avoiding the spread of infection in a radiology department. AJR Am J Roentgenol 181 (2003) 25-27
99. Fung C.P., Hsieh T.L., Tan K.H., et al. Rapid creation of a temporary isolation ward for patients with severe acute respiratory syndrome in Taiwan. Infect Control Hosp Epidemiol 25 (2004) 1026-1032
100. Tsou I.Y., Goh J.S., Kaw G.J., and Chee T.S. Severe acute respiratory syndrome: management and reconfiguration of a radiology department in an infectious disease situation. Radiology 229 (2003) 21-26
101. Rao T.N., Paul N., Chung T., et al. Value of CT in assessing probable severe acute respiratory syndrome. AJR Am J Roentgenol 181 (2003) 317-319
102. European Best Practice Guidelines Expert Group on Hemodialysis (ERA). Section VI. Haemodialysis-associated infection. Nephrol Dial Transplant 17 suppl 7 (2002) 72-87
103. Vapalahti O., Mustonen J., Lundkvist A., Henttonen H., Plyusnin A., and Vaheri A. Hantavirus infections in Europe. Lancet Infect Dis 3 (2003) 653-661
104. Kwan B.C., Leung C.B., Szeto C.C., et al. Severe acute respiratory syndrome in dialysis patients. J Am Soc Nephrol 15 (2004) 1883-1888
105. Mazuchowski E.L., and Meier P.A. The modern autopsy: what to do if infection is suspected. Arch Med Res 36 (2005) 713-723
106. Collins C.H., and Grange J.M. Tuberculosis acquired in laboratories and necropsy rooms. Commun Dis Public Health 2 (1999) 161-167
107. Newsom S.W., Rowlands C., Matthews J., and Elliot C.J. Aerosols in the mortuary. J Clin Pathol 36 (1983) 127-132
108. Nolte K.B., Foucar K., and Richmond J.Y. Hantaviral biosafety issues in the autopsy room and laboratory: concerns and recommendations. Hum Pathol 27 (1996) 1253-1254
109. Li L., Gu J., Shi X., et al. Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects. Clin Infect Dis 41 (2005) 815-821
110. Burton J.L. Health and safety at necropsy. J Clin Pathol 56 (2003) 254-260